Novel Immunotherapeutic Strategies in Melanoma with Dr Adil Daud
Dr Adil Daud from the UCSF Helen Diller Family Comprehensive Cancer Center discusses recent advances and future directions in the use of immunotherapy for the management of wild-type and BRAF-mutant melanoma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayMelanomaImmuno21).
